Fennec Pharmaceuticals Inc Stock Other OTC
Equities
CA31447P1009
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 50M | Sales 2025 * | 71.15M | Capitalization | 248M |
---|---|---|---|---|---|
Net income 2024 * | 5M | Net income 2025 * | 26M | EV / Sales 2024 * | 4.97 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.49 x |
P/E ratio 2024 * |
44
x | P/E ratio 2025 * |
9.83
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.71% |
Latest transcript on Fennec Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 09-07-06 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 11-08-24 |
Khalid Islam
CHM | Chairman | 67 | 14-04-24 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
1st Jan change | Capi. | |
---|---|---|
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |